Grey heron infected with West Nile virus A grey heron in the Noord-Holland-Noord region has tested positive for the West Nile virus. The virus is rare in the Netherlands. Bas van de Meulengraaf
Less greenhouse gas emissions across the supply chain: survey for policy development The Dutch Climate Agreement contains measures to reduce greenhouse gas emissions in the Netherlands. Many products used in the Netherlands are manufactured abroad.
Insufficient knowledge to protect the health of the Dutch population from climate change The climate is changing. This process is already affecting the health of people in the Netherlands. As such, it is important to take immediate action to prepare the Netherlands and its population for climate change and to reduce the effects on health
RIVM magazine special edition on Climate Change and Health The RIVM Magazine special edition on Climate change and Health showcases the scope of RIVM’s work on this topic.
Patient infected with West Nile virus in the Arnhem region In the past week, six human infections with the West Nile virus have been detected in the Netherlands.
First West Nile virus patient in the Netherlands A male patient has been diagnosed with the West Nile virus last week. The man has not been abroad recently. He may have contracted the virus in the region of Utrecht due to a mosquito bite.
Can you solve a medical mystery? During World Antibiotic Awareness Week 2019, RIVM has set up an escape room in one of busiest shopping malls in the Netherlands.
Young people who use screens before sleeping have more sleep problems Young people (13-18 years) who use light-emitting screens daily in the hour before going to sleep have more sleep problems.
Teen vaccination against meningococcal disease starts From mid-September, young people born between 1 May and 31 December 2004 will receive an invitation for a vaccination against meningococcal disease.
Meningococcal type W most notable infectious disease in 2017 The report ‘State of Infectious Diseases in the Netherlands in 2017’ published by RIVM today, provides an overview of the most important developments in infectious diseases in the Netherlands and a